Owens & Minor, Inc.
Summary Segment Information (unaudited)
(dollars in thousands)
The unaudited reclassified summary segment financial information below is provided to reflect the realignment of the Company's reporting segments effective during the first quarter of 2022. The Company did not operate under the realigned structure for any of these prior periods and will begin to report comparative results under the new structure effective with the filing of its Quarterly Report on Form 10-Q for the quarter ending March 31, 2022.
Reportable segment data on a quarterly basis for the year ended December 31, 2021 and on an annual basis for the years ended December 31, 2021 and 2020 is presented in the table below:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Year Ended December 31, 2021 | |
| Year Ended December 31, 2020 | | First Quarter | | Second Quarter | | Third Quarter | | Fourth Quarter | | Total | |
| Net revenue: | | | | | | | | | | | | |
| Products & Healthcare Services | $ | 7,662,429 | | | $ | 2,109,445 | | | $ | 2,255,820 | | | $ | 2,256,295 | | | $ | 2,204,086 | | | $ | 8,825,646 | | |
| Patient Direct | 817,748 | | | 217,089 | | | 233,640 | | | 245,880 | | | 263,060 | | | 959,669 | | |
| Consolidated net revenue | $ | 8,480,177 | | | $ | 2,326,534 | | | $ | 2,489,460 | | | $ | 2,502,175 | | | $ | 2,467,146 | | | $ | 9,785,315 | | |
| | | | | | | | | | | | |
| Operating income: | | | | | | | | | | | | |
| Products & Healthcare Services | $ | 215,698 | | | $ | 150,418 | | | $ | 101,229 | | | $ | 64,415 | | | $ | 68,328 | | | $ | 384,390 | | |
| Patient Direct | 67,662 | | | 12,263 | | | 14,305 | | | 14,865 | | | 16,533 | | | 57,966 | | |
| Intangible amortization | (41,490) | | | (10,026) | | | (10,026) | | | (10,025) | | | (9,730) | | | (39,807) | | |
| Acquisition-related and exit and realignment charges | (37,752) | | | (5,963) | | | (8,624) | | | (6,380) | | | (13,109) | | | (34,076) | | |
| Consolidated operating income | $ | 204,118 | | | $ | 146,692 | | | $ | 96,884 | | | $ | 62,875 | | | $ | 62,022 | | | $ | 368,473 | | |
| | | | | | | | | | | | |
| Depreciation and amortization: | | | | | | | | | | | | |
| Products & Healthcare Services | $ | 77,131 | | | $ | 19,160 | | | $ | 18,847 | | | $ | 18,868 | | | $ | 18,673 | | | $ | 75,548 | | |
| Patient Direct | 16,205 | | | 3,740 | | | 3,753 | | | 3,774 | | | 3,806 | | | 15,073 | | |
| Consolidated depreciation and amortization | $ | 93,336 | | | $ | 22,900 | | | $ | 22,600 | | | $ | 22,642 | | | $ | 22,479 | | | $ | 90,621 | | |
| | | | | | | | | | | | |
| Capital expenditures: | | | | | | | | | | | | |
| Products & Healthcare Services | $ | 58,137 | | | $ | 6,464 | | | $ | 11,806 | | | $ | 13,498 | | | $ | 16,514 | | | $ | 48,282 | | |
| Patient Direct | 1,056 | | | 159 | | | 252 | | | 446 | | | 551 | | | 1,408 | | |
| Consolidated capital expenditures | $ | 59,193 | | | $ | 6,623 | | | $ | 12,058 | | | $ | 13,944 | | | $ | 17,065 | | | $ | 49,690 | | |
